| Joseph A Capo, MD | |
|
2870 Hempstead Tpke, Suite 203, Levittown, NY 11756 | |
| (516) 731-6644 | |
| Not Available |
| Full Name | Joseph A Capo |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 10 Years |
| Location | 2870 Hempstead Tpke, Levittown, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841610979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 282374 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Joseph M Capo Md Pc | 7911899562 | 6 |
News Archive
A study has shown that most US hospitals fail to ensure that surgeons examine at least 15 lymph nodes during esophagectomy for cancer, and are therefore failing to meet guideline recommendations for detecting metastases.
Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.
Contrary to popular belief among recreational drug users, mephedrone has several important differences when compared with MDMA, commonly known as ecstasy. These differences mean that mephedrone could leave a user with acute withdrawal symptoms and indicate that it may have a higher potential for developing dependence than MDMA according to a study published in British Journal of Pharmacology.
GenVec, Inc. today reported financial results for the first quarter ended March 31, 2015. For the three months ended March 31, 2015, GenVec reported a net loss of $1.5 million, or $0.09 per share, on revenues of $0.4 million, compared with a net loss of $1.0 million, or $0.07 per share, on revenues of $2.1 million, for the same period in the prior year.
› Verified 9 days ago
| Entity Name | Joseph M Capo Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063488658 PECOS PAC ID: 7911899562 Enrollment ID: O20100216000364 |
News Archive
A study has shown that most US hospitals fail to ensure that surgeons examine at least 15 lymph nodes during esophagectomy for cancer, and are therefore failing to meet guideline recommendations for detecting metastases.
Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.
Contrary to popular belief among recreational drug users, mephedrone has several important differences when compared with MDMA, commonly known as ecstasy. These differences mean that mephedrone could leave a user with acute withdrawal symptoms and indicate that it may have a higher potential for developing dependence than MDMA according to a study published in British Journal of Pharmacology.
GenVec, Inc. today reported financial results for the first quarter ended March 31, 2015. For the three months ended March 31, 2015, GenVec reported a net loss of $1.5 million, or $0.09 per share, on revenues of $0.4 million, compared with a net loss of $1.0 million, or $0.07 per share, on revenues of $2.1 million, for the same period in the prior year.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph A Capo, MD 2870 Hempstead Tpke, Suite 203, Levittown, NY 11756 Ph: (516) 731-6644 | Joseph A Capo, MD 2870 Hempstead Tpke, Suite 203, Levittown, NY 11756 Ph: (516) 731-6644 |
News Archive
A study has shown that most US hospitals fail to ensure that surgeons examine at least 15 lymph nodes during esophagectomy for cancer, and are therefore failing to meet guideline recommendations for detecting metastases.
Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.
Contrary to popular belief among recreational drug users, mephedrone has several important differences when compared with MDMA, commonly known as ecstasy. These differences mean that mephedrone could leave a user with acute withdrawal symptoms and indicate that it may have a higher potential for developing dependence than MDMA according to a study published in British Journal of Pharmacology.
GenVec, Inc. today reported financial results for the first quarter ended March 31, 2015. For the three months ended March 31, 2015, GenVec reported a net loss of $1.5 million, or $0.09 per share, on revenues of $0.4 million, compared with a net loss of $1.0 million, or $0.07 per share, on revenues of $2.1 million, for the same period in the prior year.
› Verified 9 days ago
Dr. Barak Greenfield, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3601 Hempstead Tpke Ste 110, Levittown, NY 11756 Phone: 516-579-3050 Fax: 516-579-6233 | |
Joseph M Capo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2870 Hempstead Tpke, Ste 203, Levittown, NY 11756 Phone: 516-731-6644 Fax: 516-731-8746 | |
Dr. Eliot Danziger, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 2870 Hempstead Tpke, Levittown, NY 11756 Phone: 516-579-3050 Fax: 516-579-6233 | |
Henry C Deblasi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2870 Hempstead Tpke, Suite 203, Levittown, NY 11756 Phone: 516-731-6644 Fax: 516-731-8746 |